Clinical Trial Update: A Study of E2007 In Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial update for the investigational agent E2007 in Parkinson's disease; the study was terminated and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• E2007

Snippet

Sponsor: Eisai Inc. | Conditions: Parkinson's Disease | Phase 2 | Status: TERMINATED | Results posted: 2013-02-05